Repertoire Immune Medicines, the immunology startup formed last year by the merging of two Flagship Pioneering-founded companies, has secured $189 million as it looks to “decode” cancer, autoimmune disorders and infectious diseases, in that order.

Boston Biz Journal https://www.bizjournals.com/boston/news/2021/04/13/flagship-repertoire-immunology-startup-bags-189m.html?ana=RSS&s=article_search